These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 39296642)

  • 1. The role of long non-coding RNA NORAD in digestive system tumors.
    Pérez-Navarro Y; Salinas-Vera YM; López-Camarillo C; Figueroa-Angulo EE; Alvarez-Sánchez ME
    Noncoding RNA Res; 2025 Feb; 10():55-62. PubMed ID: 39296642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long noncoding RNA NORAD promotes the growth of gastric cancer cells by sponging miR-608.
    Miao Z; Guo X; Tian L
    Gene; 2019 Mar; 687():116-124. PubMed ID: 30453063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA NORAD contributes to the proliferation, invasion and EMT progression of prostate cancer via the miR-30a-5p/RAB11A/WNT/β-catenin pathway.
    Zhang Y; Li Y
    Cancer Cell Int; 2020 Nov; 20(1):571. PubMed ID: 33292272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncoding RNA activated by DNA damage (NORAD): Biologic function and mechanisms in human cancers.
    Yang Z; Zhao Y; Lin G; Zhou X; Jiang X; Zhao H
    Clin Chim Acta; 2019 Feb; 489():5-9. PubMed ID: 30468715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer.
    Li H; Wang X; Wen C; Huo Z; Wang W; Zhan Q; Cheng D; Chen H; Deng X; Peng C; Shen B
    Mol Cancer; 2017 Nov; 16(1):169. PubMed ID: 29121972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARID3A and ARID3B exert direct regulatory control over the long non-coding RNAs (lncRNAs) MALAT1 and NORAD within the context of non-small cell lung cancer (NSCLC).
    Nasuh S; Balci SO; Bozgeyik I; Ikeda MA; Tekayev M; Saadat KASM
    Pathol Res Pract; 2023 Dec; 252():154948. PubMed ID: 37977034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of Long Non-Coding RNA (LncRNA) Non-Coding RNA Activated by DNA Damage (NORAD) Inhibits Proliferation, Invasion, Migration, and Promotes Apoptosis of Glioma Cells via Downregulating the Expression of AKR1B1.
    Luo L; Chen C; He H; Cai M; Ling C
    Med Sci Monit; 2020 Jul; 26():e922659. PubMed ID: 32778640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NORAD, a critical long non-coding RNA in human cancers.
    Soghli N; Yousefi T; Abolghasemi M; Qujeq D
    Life Sci; 2021 Jan; 264():118665. PubMed ID: 33127516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA NORAD upregulate SIP1 expression to promote cell proliferation and invasion in cervical cancer.
    Huo H; Tian J; Wang R; Li Y; Qu C; Wang N
    Biomed Pharmacother; 2018 Oct; 106():1454-1460. PubMed ID: 30119219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA NORAD promotes pancreatic cancer stem cell proliferation and self-renewal by blocking microRNA-202-5p-mediated ANP32E inhibition.
    Ma YS; Yang XL; Liu YS; Ding H; Wu JJ; Shi Y; Jia CY; Lu GX; Zhang DD; Wang HM; Wang PY; Yu F; Lv ZW; Wang GR; Liu JB; Fu D
    J Transl Med; 2021 Sep; 19(1):400. PubMed ID: 34551785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA NORAD inhibition upregulates microRNA-323a-3p to suppress tumorigenesis and development of breast cancer through the PUM1/eIF2 axis.
    Shi P; Zhang J; Li X; Li W; Li H; Fu P
    Cell Cycle; 2021 Jul; 20(13):1295-1307. PubMed ID: 34125645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long noncoding RNA noncoding RNA activated by DNA damage (NORAD)-microRNA-496-Interleukin-33 axis affects carcinoma-associated fibroblasts-mediated gastric cancer development.
    Huang C; Liu J; He L; Wang F; Xiong B; Li Y; Yang X
    Bioengineered; 2021 Dec; 12(2):11738-11755. PubMed ID: 34895039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA-non-coding RNA activated by DNA damage inhibition suppresses hepatic stellate cell activation via microRNA-495-3p/sphingosine 1-phosphate receptor 3 axis.
    Zou L; Shi C; Wang D; Cheng J; Wang Q; Wang L; Yang G
    Bioengineered; 2022 Mar; 13(3):6150-6162. PubMed ID: 35200103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p.
    Wang B; Xu L; Zhang J; Cheng X; Xu Q; Wang J; Mao F
    Biomed Pharmacother; 2020 Sep; 129():110268. PubMed ID: 32563146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA NORAD acts as a ceRNA mediates gemcitabine resistance in bladder cancer by sponging miR-155-5p to regulate WEE1 expression.
    Yang Y; Zhang G; Li J; Gong R; Wang Y; Qin Y; Ping Q; Hu L
    Pathol Res Pract; 2021 Dec; 228():153676. PubMed ID: 34753061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural characterization of NORAD reveals a stabilizing role of spacers and two new repeat units.
    Chorostecki U; Saus E; Gabaldón T
    Comput Struct Biotechnol J; 2021; 19():3245-3254. PubMed ID: 34141143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA
    Chen X; Pan T; Guo G; Chen G; Cai Y; Tang Y; Wang Y; Wang Y; Deng Z; Li L; Zhou Y
    J Gastrointest Oncol; 2022 Dec; 13(6):2832-2844. PubMed ID: 36636064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA NORAD/miR-224-3p/MTDH axis contributes to CDDP resistance of esophageal squamous cell carcinoma by promoting nuclear accumulation of β-catenin.
    Jia Y; Tian C; Wang H; Yu F; Lv W; Duan Y; Cheng Z; Wang X; Wang Y; Liu T; Wang J; Liu L
    Mol Cancer; 2021 Dec; 20(1):162. PubMed ID: 34893064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA NORAD, sponging miR-363-3p, promotes invasion and EMT by upregulating PEAK1 and activating the ERK signaling pathway in NSCLC cells.
    Geng Q; Li Z; Li X; Wu Y; Chen N
    J Bioenerg Biomembr; 2021 Jun; 53(3):321-332. PubMed ID: 33742335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA NORAD promotes the prostate cancer cell extracellular vesicle release via microRNA-541-3p-regulated PKM2 to induce bone metastasis of prostate cancer.
    Hu CY; Chen J; Qin XH; You P; Ma J; Zhang J; Zhang H; Xu JD
    J Exp Clin Cancer Res; 2021 Mar; 40(1):98. PubMed ID: 33722248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.